You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The firm reported that it expects product and service revenue of approximately $23.5 million for the fourth quarter of last year and $83.5 million for full-year 2018.
While the first task of the centers will be to digitize their workflows to improve efficiency, they also aim to eventually develop new AI-based analytical tools for diagnosing patients.
Relying on artificial intelligence, the company has crafted a software tool to assist pathologists in diagnosing cancers and delivering clinical reports.
The platform is currently used by pathologists doing research and could be available in a year for primary diagnosis of cancers in clinical settings.
Nikon will distribute OptraScan's whole-slide imaging scanners, as well as its integrated telepathology, and AI- and machine learning-based analytics solutions.
Under one agreement, LabCorp will help Baptist Health establish a core lab. Its deal with Definiens is aimed at companion diagnostics development.
The company raised $3.2 million in seed financing, which will go toward development of its platform and deployment of its flagship technology called VIPER.
The firm will use the funds to expand deployment of its digital pathology software and accelerate use of artificial intelligence applications.
When it comes to interfaces, storage, outcomes reporting, and HIPAA compliance, molecular lab personnel might need to demand more from their LIS vendors, researchers said.
The companies announced a strategic venture to provide comprehensive biomarker profiling to empower clinical trials in the immuno-oncology space.